Stockscreener 앱 받기
12.19
5.45%
0.63
시간 외 거래:
12.38
0.19
+1.56%
전일 마감가:
$11.56
열려 있는:
$11.64
하루 거래량:
1.10M
Relative Volume:
1.25
시가총액:
$1.30B
수익:
$247.00M
순이익/손실:
$-249.00M
주가수익비율:
-3.945
EPS:
-3.09
순현금흐름:
$-267.00M
1주 성능:
+15.11%
1개월 성능:
+27.64%
6개월 성능:
+24.26%
1년 성능:
-24.52%
1일 변동 폭
$11.53
$12.24
1주일 범위
$10.55
$12.24
52주 변동 폭
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
명칭
Arcus Biosciences Inc
전화
(510) 694-6200
주소
3928 POINT EDEN WAY, HAYWARD, CA
RCUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
12.19 | 1.23B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | 개시 | H.C. Wainwright | Neutral |
| 2024-10-08 | 개시 | Wells Fargo | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Overweight |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-11-23 | 개시 | Evercore ISI | Outperform |
| 2020-04-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-09-27 | 개시 | Mizuho | Buy |
| 2019-05-24 | 재개 | Citigroup | Buy |
| 2018-10-09 | 개시 | Wedbush | Outperform |
| 2018-04-09 | 개시 | Citigroup | Buy |
| 2018-04-09 | 개시 | Goldman | Neutral |
| 2018-04-09 | 개시 | Leerink Partners | Outperform |
모두보기
Arcus Biosciences Inc 주식(RCUS)의 최신 뉴스
There's No Escaping Arcus Biosciences, Inc.'s (NYSE:RCUS) Muted Revenues Despite A 28% Share Price Rise - simplywall.st
Using data filters to optimize entry into Arcus Biosciences Inc.2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Is Arcus Biosciences Inc. stock a smart retirement pickWeekly Profit Report & Daily Profit Focused Screening - خودرو بانک
Why Arcus Biosciences Inc. is moving todayWeekly Volume Report & Step-by-Step Swing Trade Plans - Newser
What drives Arcus Biosciences Inc.’s stock priceTake Profit & Community Verified Trade Alerts - خودرو بانک
Strategies to average down on Arcus Biosciences Inc.Weekly Investment Summary & Accurate Buy Signal Alerts - Newser
Smart tools for monitoring Arcus Biosciences Inc.’s price actionJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - Newser
Using Ichimoku Cloud for Arcus Biosciences Inc. technicalsJuly 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
What to do if you’re stuck in Arcus Biosciences Inc.2025 Top Gainers & Low Risk Entry Point Guides - Newser
What to expect from Arcus Biosciences Inc. in the next 30 daysEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Is Arcus Biosciences Inc. forming a bottoming baseWeekly Earnings Recap & Fast Entry Momentum Alerts - Newser
What recovery options are there for Arcus Biosciences Inc.Quarterly Profit Review & AI Powered Market Trend Analysis - Newser
Candlestick signals on Arcus Biosciences Inc. stock today2025 Price Momentum & Daily Market Momentum Tracking - Newser
Published on: 2025-09-04 03:31:21 - Newser
Arcus Biosciences Inc.’s volatility index tracking explainedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser
Is Arcus Biosciences Inc. stock bottoming outWeekly Earnings Recap & Community Verified Trade Signals - Newser
Is Arcus Biosciences Inc. in a long term uptrendTrade Risk Assessment & Risk Managed Investment Entry Signals - خودرو بانک
What machine learning models say about Arcus Biosciences Inc.2025 Biggest Moves & Real-Time Volume Triggers - Newser
Sector ETF performance correlation with Arcus Biosciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Transcript : Arcus Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 11 - MarketScreener
Arcus Biosciences shares rise 7.26% intraday after announcing an Investor Event to highlight new data for its HIF-2a inhibitor casdatifan. - AInvest
Will Arcus Biosciences Inc. see short term momentumJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Arcus Biosciences Inc. stock trend forecastTrade Signal Summary & High Win Rate Trade Tips - Newser
Leading vs lagging indicators on Arcus Biosciences Inc. performanceQuarterly Profit Report & Real-Time Buy Signal Notifications - Newser
Applying Wyckoff theory to Arcus Biosciences Inc. stock2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Arcus Biosciences Inc. stock daily chart insightsJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Key Cancer Drug Trial Results Coming: Arcus Biosciences to Reveal Casdatifan Data for Kidney Cancer - Stock Titan
News impact scoring models applied to Arcus Biosciences Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
What moving averages say about Arcus Biosciences Inc.2025 Major Catalysts & Technical Entry and Exit Tips - Newser
Backtesting results for Arcus Biosciences Inc. trading strategiesEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Using Bollinger Bands to evaluate Arcus Biosciences Inc.2025 Market WrapUp & Safe Capital Allocation Plans - Newser
Is Arcus Biosciences Inc. stock technically oversold2025 Bull vs Bear & Low Risk High Reward Trade Ideas - خودرو بانک
Is Arcus Biosciences Inc. forming higher highs and higher lows2025 Trading Volume Trends & Stock Portfolio Risk Management - خودرو بانک
Arcus Biosciences Inc. Outperforms Peers on Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
Chart overlay techniques for tracking Arcus Biosciences Inc.Quarterly Portfolio Report & Real-Time Volume Analysis - Newser
Arcus Biosciences Inc (RCUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):